EU Rejects Calls To Extend Clinical Trial Regulation Transition Period
Sponsors Worried About Member State Preparedness Are Reminded About Tacit Approval
Executive Summary
A senior European Commission official has a clear answer for those expecting the mandatory phase of the EU Clinical Trial Regulation to be delayed. There is no such plan on the cards.
You may also be interested in...
Mandatory Use Of ‘Dysfunctional’ EU Clinical Trial Portal Raises Concern In Germany
Efforts are on to address the “serious deficiencies” raised by the German associations for medical ethics committees, trial sponsors, contract research organizations and other stakeholders regarding the EU Clinical Trial Information System that will become mandatory from 31 January 2023.
EU Promises ‘Unifying’ Stakeholder Forum To Discuss Changes To Clinical Trial Landscape
The new workplan for the EU's initiative on accelerating clinical trials lays out the timelines for a set of “priority actions,” such as mapping the European clinical trial environment and establishing a consolidated process for more efficiently managing scientific advice on trials.
So Far So Good: EU Member States On ‘Limited’ Experience With Clinical Trial Portal
At a recent webinar on the EU Clinical Trial Information System (CTIS), representatives from different EU member states said the new system was working well and highlighted certain “good practices” for study sponsors to consider.